
Amber D. Steele
Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1639, 1658, 1676 |
| Total Applications | 1302 |
| Issued Applications | 628 |
| Pending Applications | 166 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19724037
[patent_doc_number] => 20250026788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-23
[patent_title] => PEPTIDES FOR THE TREATMENT OF CHRONICALLY ACTIVE AUTOIMMUNE INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 18/572259
[patent_app_country] => US
[patent_app_date] => 2022-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18572259
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/572259 | PEPTIDES FOR THE TREATMENT OF CHRONICALLY ACTIVE AUTOIMMUNE INFLAMMATION | Jun 22, 2022 | Pending |
Array
(
[id] => 18337989
[patent_doc_number] => 20230129938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => METHODS OF TREATING NEUROLOGICAL DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/844647
[patent_app_country] => US
[patent_app_date] => 2022-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21470
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17844647
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/844647 | METHODS OF TREATING NEUROLOGICAL DISEASES | Jun 19, 2022 | Pending |
Array
(
[id] => 19473875
[patent_doc_number] => 12103951
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-01
[patent_title] => Use of CGRP receptor antagonists in neuroprotection and neurological disorders
[patent_app_type] => utility
[patent_app_number] => 17/806834
[patent_app_country] => US
[patent_app_date] => 2022-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 29671
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 208
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17806834
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/806834 | Use of CGRP receptor antagonists in neuroprotection and neurological disorders | Jun 13, 2022 | Issued |
Array
(
[id] => 18364673
[patent_doc_number] => 20230146264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => Treatment of Ascites
[patent_app_type] => utility
[patent_app_number] => 17/831556
[patent_app_country] => US
[patent_app_date] => 2022-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3085
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17831556
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/831556 | Treatment of Ascites | Jun 2, 2022 | Abandoned |
Array
(
[id] => 19497643
[patent_doc_number] => 20240336661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => PEPTIDES DERIVED FROM RUMINOCOCCUS TORQUES
[patent_app_type] => utility
[patent_app_number] => 18/564398
[patent_app_country] => US
[patent_app_date] => 2022-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34611
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18564398
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/564398 | PEPTIDES DERIVED FROM RUMINOCOCCUS TORQUES | Jun 1, 2022 | Pending |
Array
(
[id] => 19923022
[patent_doc_number] => 12297293
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-13
[patent_title] => Peptide compounds targeting PD-1 receptor as well as preparation and applications thereof
[patent_app_type] => utility
[patent_app_number] => 18/568525
[patent_app_country] => US
[patent_app_date] => 2022-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 0
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18568525
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/568525 | Peptide compounds targeting PD-1 receptor as well as preparation and applications thereof | May 31, 2022 | Issued |
Array
(
[id] => 19380940
[patent_doc_number] => 20240270810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => PREPARATION AND APPLICATION OF POLYPEPTIDE
[patent_app_type] => utility
[patent_app_number] => 18/288796
[patent_app_country] => US
[patent_app_date] => 2022-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18288796
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/288796 | PREPARATION AND APPLICATION OF POLYPEPTIDE | May 29, 2022 | Pending |
Array
(
[id] => 20192272
[patent_doc_number] => 20250268982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-28
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT AND/OR PROPHYLAXIS OF PROTEINOPATHIES
[patent_app_type] => utility
[patent_app_number] => 18/563420
[patent_app_country] => US
[patent_app_date] => 2022-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563420
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/563420 | COMPOSITIONS AND METHODS FOR TREATMENT AND/OR PROPHYLAXIS OF PROTEINOPATHIES | May 25, 2022 | Pending |
Array
(
[id] => 17852197
[patent_doc_number] => 20220282239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY
[patent_app_type] => utility
[patent_app_number] => 17/749004
[patent_app_country] => US
[patent_app_date] => 2022-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5844
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17749004
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/749004 | MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY | May 18, 2022 | Abandoned |
Array
(
[id] => 19316833
[patent_doc_number] => 20240238373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => Use of Erythropoietin (EPO) or Erythropoiesis-Stimulating Agent (ESA) to Treat Osteomyelitis, Bone Infection, and Bone Inflammation
[patent_app_type] => utility
[patent_app_number] => 18/290297
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8409
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18290297
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/290297 | Use of Erythropoietin (EPO) or Erythropoiesis-Stimulating Agent (ESA) to Treat Osteomyelitis, Bone Infection, and Bone Inflammation | May 15, 2022 | Pending |
Array
(
[id] => 17895440
[patent_doc_number] => 20220305102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => TREATMENT OF HAEMATOLOGICAL MALIGNANCIES
[patent_app_type] => utility
[patent_app_number] => 17/744568
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47677
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744568
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/744568 | TREATMENT OF HAEMATOLOGICAL MALIGNANCIES | May 12, 2022 | Pending |
Array
(
[id] => 19464140
[patent_doc_number] => 20240317809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => Engineered Antimicrobial Peptides and Usage Thereof
[patent_app_type] => utility
[patent_app_number] => 18/290214
[patent_app_country] => US
[patent_app_date] => 2022-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37773
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -65
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18290214
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/290214 | Engineered Antimicrobial Peptides and Usage Thereof | May 11, 2022 | Pending |
Array
(
[id] => 17837721
[patent_doc_number] => 20220275026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => IL-2RBETA BINDING COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/741020
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 111515
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 310
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17741020
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/741020 | IL-2RBETA BINDING COMPOUNDS | May 9, 2022 | Abandoned |
Array
(
[id] => 18250565
[patent_doc_number] => 20230077604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => ANTIMICROBIAL PEPTIDES AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/738572
[patent_app_country] => US
[patent_app_date] => 2022-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17738572
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/738572 | Antimicrobial peptides and methods of using same | May 5, 2022 | Issued |
Array
(
[id] => 20163888
[patent_doc_number] => 20250255934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-14
[patent_title] => COMPOSITIONS FOR TREATING INFLAMMATORY AIRWAY DISEASE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/559118
[patent_app_country] => US
[patent_app_date] => 2022-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17682
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18559118
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/559118 | COMPOSITIONS FOR TREATING INFLAMMATORY AIRWAY DISEASE AND USES THEREOF | May 5, 2022 | Pending |
Array
(
[id] => 19297740
[patent_doc_number] => 20240226306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => TREM-2/DAP-12 INHIBITORS FOR TREATING LUNG DISEASE AND INJURY AND COMBINATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/560300
[patent_app_country] => US
[patent_app_date] => 2022-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38513
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18560300
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/560300 | TREM-2/DAP-12 INHIBITORS FOR TREATING LUNG DISEASE AND INJURY AND COMBINATIONS THEREOF | May 4, 2022 | Pending |
Array
(
[id] => 18034487
[patent_doc_number] => 20220378702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => PEPTIDE-LIPID CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 17/737862
[patent_app_country] => US
[patent_app_date] => 2022-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17737862
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/737862 | PEPTIDE-LIPID CONJUGATES | May 4, 2022 | Pending |
Array
(
[id] => 18198175
[patent_doc_number] => 20230051694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => POLYPEPTIDE FRAGMENT B (MP-B) AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/737058
[patent_app_country] => US
[patent_app_date] => 2022-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2845
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17737058
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/737058 | POLYPEPTIDE FRAGMENT B (MP-B) AND USE THEREOF | May 4, 2022 | Abandoned |
Array
(
[id] => 18124145
[patent_doc_number] => 20230009757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-12
[patent_title] => COMBINATION THERAPY FOR C3 INHIBITION
[patent_app_type] => utility
[patent_app_number] => 17/719074
[patent_app_country] => US
[patent_app_date] => 2022-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 105502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17719074
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/719074 | COMBINATION THERAPY FOR C3 INHIBITION | Apr 11, 2022 | Pending |
Array
(
[id] => 20744032
[patent_doc_number] => 12643923
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-02
[patent_title] => Method of clarifying a crude protein solution
[patent_app_type] => utility
[patent_app_number] => 18/549552
[patent_app_country] => US
[patent_app_date] => 2022-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 0
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18549552
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/549552 | Method of clarifying a crude protein solution | Apr 10, 2022 | Issued |